Purpose: Increase urine output by blocking sodium (Na⁺) reabsorption; water follows sodium.
-
Main Classes:
-
Carbonic Anhydrase Inhibitors
-
Loop Diuretics
-
Thiazide Diuretics
-
Potassium-Sparing Diuretics
-
2. Carbonic Anhydrase Inhibitors
-
Prototype: Acetazolamide
-
Site: Proximal Tubule
-
Mechanism: Inhibits carbonic anhydrase → reduces Na⁺ & HCO₃⁻ reabsorption → mild diuresis, metabolic acidosis
-
Indications: Altitude sickness, glaucoma, intracranial hypertension, adjunct in hypervolemia with alkalosis
-
Complications: Metabolic acidosis
3. Loop Diuretics
-
Prototypes: Furosemide, Torsemide, Bumetanide
-
Site: Thick Ascending Limb of Loop of Henle
-
Mechanism: Blocks NKCC2 → Na⁺, K⁺, Cl⁻ loss; disrupts Ca²⁺/Mg²⁺ reabsorption
-
Effect: Powerful diuresis, distal Na⁺ delivery ↑ → K⁺/H⁺ excretion
-
Indications: Hypervolemia (CHF, pulmonary edema, cirrhosis), hyperkalemia
-
Complications: Hypovolemia, hypokalemia, metabolic alkalosis, hypocalcemia, hypomagnesemia, hyperuricemia, ototoxicity
4. Thiazide Diuretics
-
Prototypes: Hydrochlorothiazide, Chlorthalidone, Metolazone
-
Site: Early Distal Tubule
-
Mechanism: Blocks Na⁺-Cl⁻ cotransporter → Na⁺/water loss; Ca²⁺ reabsorption ↑
-
Effect: Moderate diuresis, distal Na⁺ delivery ↑ → K⁺/H⁺ excretion
-
Indications: Hypertension, hypervolemia adjunct, hypercalciuria, osteoporosis
-
Complications: Hyponatremia, hypokalemia, metabolic alkalosis, hyperuricemia, hypercalcemia, hypotension
5. Potassium-Sparing Diuretics
-
Site: Late Distal Tubule / Collecting Duct
-
Subtypes:
-
Aldosterone Antagonists: Spironolactone, Eplerenone → block aldosterone → ↓ ENaC → K⁺ retention
-
Direct ENaC Blockers: Amiloride, Triamterene → block ENaC directly
-
-
Effect: Weak diuresis, conserves K⁺ and H⁺
-
Indications: Adjunct for hypervolemia with hypokalemia, hyperaldosteronism, CHF, cirrhosis
-
Complications: Hyperkalemia, metabolic acidosis, hyponatremia; spironolactone → gynecomastia
6. Clinical Approach
-
Assess Volume Status:
-
Hypervolemia → JVD, edema, crackles → avoid fluids
-
Hypovolemia → dry mucosa, hypotension, tachycardia → diuretic may be indicated
-
-
Choose & Titrate Diuretic:
-
Loop diuretics for first-line hypervolemia
-
Use threshold and ceiling doses; IV → PO = 1:2
-
-
Add Adjuncts:
-
Persistent hypervolemia + hypernatremia → add thiazide
-
Persistent hypervolemia + hypokalemia → add K⁺-sparing
-
Persistent alkalosis → add acetazolamide
-
-
Monitor: Daily weights, electrolytes (Na⁺, K⁺, Mg²⁺, Ca²⁺), creatinine, volume status
7. Summary Table
| Class | Site | Mechanism | Effect | Indications | Key Complications |
|---|---|---|---|---|---|
| Carbonic Anhydrase Inhibitor | Proximal Tubule | Inhibits CA | Mild Na⁺/H₂O loss, HCO₃⁻ loss | Altitude sickness, glaucoma, adjunct | Metabolic acidosis |
| Loop | Thick Ascending Limb | Blocks NKCC2 | Powerful Na⁺/H₂O loss, K⁺/H⁺ excretion | Hypervolemia (1st line), hyperkalemia | Hypovolemia, hypokalemia, metabolic alkalosis, ototoxicity |
| Thiazide | Early Distal Tubule | Blocks Na⁺-Cl⁻ cotransporter | Moderate Na⁺/H₂O loss, Ca²⁺ retention | Hypertension, hypercalciuria, adjunct | Hyponatremia, hypokalemia, hyperuricemia, hypercalcemia |
| K⁺-Sparing | Collecting Duct | Blocks ENaC / Aldosterone | Weak diuresis, K⁺ retention | Adjunct for hypokalemia, CHF, cirrhosis | Hyperkalemia, metabolic acidosis, gynecomastia |
No comments:
Post a Comment